Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Feasibility Study of Prostate Cancer Radiotherapy Gating Using kV Intrafraction Monitoring (KIM)

NCT01742403 is registered in ClinicalTrials.gov with Royal North Shore Hospital as lead sponsor.

NCT NCT01742403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01742403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Feasibility Study of Prostate Cancer Radiotherapy Gating Using kV Intrafraction Monitoring (KIM)
Lead sponsor
Royal North Shore Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2013
Completion date
June 30, 2028
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer